CN106659676A - 一种罗哌卡因缓释凝胶制剂及其制备与应用 - Google Patents

一种罗哌卡因缓释凝胶制剂及其制备与应用 Download PDF

Info

Publication number
CN106659676A
CN106659676A CN201580038632.XA CN201580038632A CN106659676A CN 106659676 A CN106659676 A CN 106659676A CN 201580038632 A CN201580038632 A CN 201580038632A CN 106659676 A CN106659676 A CN 106659676A
Authority
CN
China
Prior art keywords
ropivacaine
gel
sustained
release gel
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580038632.XA
Other languages
English (en)
Inventor
叶强
严庞科
张轩邈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Haisco Pharmaceutical Co Ltd
Original Assignee
Sichuan Haisco Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Haisco Pharmaceutical Co Ltd filed Critical Sichuan Haisco Pharmaceutical Co Ltd
Publication of CN106659676A publication Critical patent/CN106659676A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

罗哌卡因缓释凝胶制剂、其制备方法及用途,所述凝胶制剂包括1‑20wt%的罗哌卡因、14‑22wt%的泊洛沙姆407和余量的水或盐溶液。

Description

PCT国内申请,说明书已公开。

Claims (34)

  1. PCT国内申请,权利要求书已公开。
CN201580038632.XA 2014-11-05 2015-11-05 一种罗哌卡因缓释凝胶制剂及其制备与应用 Pending CN106659676A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2014106181617 2014-11-05
CN201410618161 2014-11-05
PCT/CN2015/093883 WO2016070826A1 (zh) 2014-11-05 2015-11-05 一种罗哌卡因缓释凝胶制剂及其制备与应用

Publications (1)

Publication Number Publication Date
CN106659676A true CN106659676A (zh) 2017-05-10

Family

ID=55908605

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580038632.XA Pending CN106659676A (zh) 2014-11-05 2015-11-05 一种罗哌卡因缓释凝胶制剂及其制备与应用

Country Status (2)

Country Link
CN (1) CN106659676A (zh)
WO (1) WO2016070826A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116172943B (zh) * 2023-02-15 2024-01-26 上海市肿瘤研究所 一种可注射的缓释凝胶制剂及其制备与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
CN103816111B (zh) * 2014-02-26 2016-08-17 中国人民解放军第二军医大学 一种罗哌卡因纳米脂质载体温敏原位凝胶及其制备方法

Also Published As

Publication number Publication date
WO2016070826A1 (zh) 2016-05-12

Similar Documents

Publication Publication Date Title
EP1809329B1 (en) Sustained local anesthetic composition containing saib
TWI489984B (zh) 用於非經腸道傳輸化合物之配方及其用途
JP6205676B2 (ja) 非依存性の鎮痛徐放性ドラッグデリバリーシステム及びその製造方法
WO2017036408A1 (zh) S-(-)-1-丙基-2',6'-二甲苯胺甲酰基哌啶晶体及其缓释制剂
JP6898980B2 (ja) 延長された持続時間の局所麻酔薬製剤
WO2019074701A1 (en) STABLE OPIOID ANTAGONIST SOLUTIONS AT LOW TEMPERATURE
Hung et al. Cutaneous analgesia and systemic toxicity of carbetapentane and caramiphen in rats
JP2001513814A (ja) 小児科手術におけるレボブピバカインの使用
CN110327336B (zh) 昔萘酸甲哌卡因及其长效缓释制剂
CN106659676A (zh) 一种罗哌卡因缓释凝胶制剂及其制备与应用
CN114522141A (zh) 一种罗哌卡因混悬注射液及其制备方法
US11672863B2 (en) Enhanced solubility drug-containing formulations
DK2611445T3 (en) HIGH DOSAGE-BUPRENORPHINE COMPOSITIONS AND USE AS ANALGETIC
WO2022193975A1 (zh) 供注射用罗哌卡因长效溶液制剂及其制备方法
JP2001510794A (ja) レボブピバカインとその使用
US20220202793A1 (en) Sustained release local anesthetic hydrogel composition
WO2007022609A1 (en) Pharmaceutical composition of morphine in ready-to-use injectable solution form and single dosage form of morphine for epidural or intrathecal administration
US20190365730A1 (en) Anaesthetic composition comprising ropivacaine, prilocaine and lidocaine
Hasanbegovic et al. COMPARISON OF SENSORY AND MOTOR PERIPHERAL NERVE BLOCKADES WITH 1.33% LIPOSOMAL BUPIVACAINE, 1% ROPIVACAINE AND 2% LIDOCAINE WITH DEXAMETHASONE
EP3656378A1 (en) New composition of amide and ester local anesthetics and uses thereof
CN113616796A (zh) 一种止痛抗炎复方缓释制剂
CN116099007A (zh) 一种局麻药与生物碱的帕莫酸盐缓释组合物
MXPA00000397A (es) Levobupivacaina y su uso

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170510

WD01 Invention patent application deemed withdrawn after publication